Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

[Clinical trial endpoints in alpha-1-antitrypsin deficiency: interdisciplinary aspects].

Steinkamp G, Köhnlein T, Ley-Zaporozhan J, Wegscheider K, Buhl R.

Pneumologie. 2011 Apr;65(4):229-35. doi: 10.1055/s-0030-1256017. Epub 2011 Jan 14. Review. German. Erratum in: Pneumologie. 2011 Apr;65(4):e49.

2.

Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening.

de Serres FJ, Blanco I, Fernández-Bustillo E.

COPD. 2006 Aug;3(3):133-9. Erratum in: COPD. 2006 Dec;3(4):245.

PMID:
17240615
4.

Genetic and biochemical markers of obstructive lung disease in the general population.

Dahl M.

Clin Respir J. 2009 Apr;3(2):121-2. doi: 10.1111/j.1752-699X.2008.00110.x.

PMID:
20298391
5.

A review of alpha-1 antitrypsin deficiency.

Ranes J, Stoller JK.

Semin Respir Crit Care Med. 2005 Apr;26(2):154-66. Review.

PMID:
16088434
6.

Quantitative computed tomography and aerosol morphometry in COPD and alpha1-antitrypsin deficiency.

Shaker SB, Maltbaek N, Brand P, Haeussermann S, Dirksen A.

Eur Respir J. 2005 Jan;25(1):23-30.

7.

[Alpha-1 antitrypsin deficiency: diagnosis and treatment].

Camelier AA, Winter DH, Jardim JR, Barboza CE, Cukier A, Miravitlles M.

J Bras Pneumol. 2008 Jul;34(7):514-27. Review. Portuguese.

9.

Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.

Strange C, Senior RM, Sciurba F, O'Neal S, Morris A, Wisniewski SR, Bowler R, Hochheiser HS, Becich MJ, Zhang Y, Leader JK, Methé BA, Kaminski N, Sandhaus RA; GRADS Alpha-1 Study Group.

Ann Am Thorac Soc. 2015 Oct;12(10):1551-60. doi: 10.1513/AnnalsATS.201503-143OC.

10.

[Alpha1-antitrypsin deficiency: situation in Spain and development of a screening program].

de la Roza C, Lara B, Vilà S, Miravitlles M.

Arch Bronconeumol. 2006 Jun;42(6):290-8. Review. Spanish.

11.

Recent advances in α-1-antitrypsin deficiency-related lung disease.

Brebner JA, Stockley RA.

Expert Rev Respir Med. 2013 Jun;7(3):213-29; quiz 230. doi: 10.1586/ers.13.20. Review.

PMID:
23734645
12.

[COPD and alpha-1-antitrypsin deficiency].

Lara B.

Arch Bronconeumol. 2010;46 Suppl 4:2-8. doi: 10.1016/S0300-2896(10)70026-0. Spanish.

13.

Asthma and COPD in alpha-1 antitrypsin deficiency. Evidence for the Dutch hypothesis.

Eden E.

COPD. 2010 Oct;7(5):366-74. doi: 10.3109/15412555.2010.510159. Review.

PMID:
20854052
14.

Familial risks for chronic obstructive pulmonary disease among siblings based on hospitalisations in Sweden.

Hemminki K, Li X, Sundquist K, Sundquist J.

J Epidemiol Community Health. 2008 May;62(5):398-401. doi: 10.1136/jech.2007.063156.

PMID:
18413451
15.

Primary care diagnosis of alpha-1 antitrypsin deficiency: issues and opportunities.

Stoller JK, Fromer L, Brantly M, Stocks J, Strange C.

Cleve Clin J Med. 2007 Dec;74(12):869-74. Review.

PMID:
18183837
16.

[Update: Alpha-1-antitrypsin deficiency. Summary of a scientific symposium at the conference of the Swiss Pneumologic Society on April 16th, 2009].

Vogelmeier C, Hamacher J, Steveling H, Steinkamp G.

Pneumologie. 2009 Dec;63(12):718-25. doi: 10.1055/s-0029-1215207. Epub 2009 Nov 25. German.

17.

Alpha-1-antitrypsin replacement therapy: current status.

Abusriwil H, Stockley RA.

Curr Opin Pulm Med. 2006 Mar;12(2):125-31. Review.

PMID:
16456382
18.

alpha1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants.

Senn O, Russi EW, Imboden M, Probst-Hensch NM.

Eur Respir J. 2005 Nov;26(5):909-17.

19.

Progression of emphysema evaluated by MRI using hyperpolarized (3)He (HP (3)He) measurements in patients with alpha-1-antitrypsin (A1AT) deficiency compared with CT and lung function tests.

Stavngaard T, Søgaard LV, Batz M, Schreiber LM, Dirksen A.

Acta Radiol. 2009 Nov;50(9):1019-26. doi: 10.3109/02841850903213822.

PMID:
19863412

Supplemental Content

Support Center